On September 26, 2018, you may have seen a special insert in the paper version of the National Post across the country, featuring eight pages of informative articles about immunotherapy, an innovative treatment proving successful in several cancer indications. This special content is the result of a collaboration between sponsoring funders, patient group representatives, and the folks at a group called Patient Diaries. Over the years, Patient Diaries has coordinated several series such as this, raising awareness of various diseases and their effective treatments. This time they chose to highlight Immuno-Oncology.
Researchers and clinicians treating metastatic melanoma have been seeing success with these therapies for about ten years, but the growing use of and experimentation with them in recent years has been the topic of discussion at countless oncology conferences and treatment centres around the world. In fact, just last month the 2018 Nobel Prize in Physiology or Medicine was awarded to James P. Allison and Tasuku Honjo for their discovery of cancer therapy by inhibition of negative immune regulation: immunotherapy.
Save Your Skin Foundation openly discusses the need for access to these treatments by melanoma patients across Canada, and we jumped on the opportunity to be the primary patient group sponsor of this feature, sharing our collective patient experience with these therapies. On page six of the insert there was an article in which both Kathy Barnard and Natalie Richardson of Save Your Skin were interviewed. We were also given half a page to display informative anecdotes about ourselves and raise awareness of our ongoing support of skin cancer patients.
In addition to the paper version of the Therapeutic Spotlight, a digital space has been placed on the National Post website. SYSF awareness spots and our patient video from May 2018 can be seen throughout the Immuno-Oncology board – please feel free to take a look around. There are additional informative articles about innovative treatments for lung cancer, leukemia, and breast cancer.
There is also a blog written by Natalie Richardson, melanoma survivor and Managing Director of SYSF, discussing the barriers to treatment access that many Canadian patients face. Click here to read the blog: Cancer Patients Receive Unequal Treatment Depending on Stage or Postal Code
To see what else SYSF is talking about, click here to visit our MEDIA page!